AU4303500A - Use of (2s)-1- ((2r,3s)-5-chloro-3- (2-chlorophenyl)- 1-(3,4-dimethoxybenzenesulfonyl)- 3-hydroxy-2,3- dihydro-1(h)- indole-2-carbonyl) pyrrolidine- 2-carboxamide in the production of medicaments used to treat raynaud's phenomenon - Google Patents

Use of (2s)-1- ((2r,3s)-5-chloro-3- (2-chlorophenyl)- 1-(3,4-dimethoxybenzenesulfonyl)- 3-hydroxy-2,3- dihydro-1(h)- indole-2-carbonyl) pyrrolidine- 2-carboxamide in the production of medicaments used to treat raynaud's phenomenon

Info

Publication number: AU4303500A
Authority: AU; Australia
Prior art keywords: dimethoxybenzenesulfonyl; carboxamide; pyrrolidine; indole; chlorophenyl
Prior art date: 1999-04-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU43035/00A

Inventor

Remi Brouard

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis France

Original Assignee

Sanofi Synthelabo SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-29

Filing date

2000-04-25

Publication date

2000-11-17

2000-04-25 Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA

2000-11-17 Publication of AU4303500A publication Critical patent/AU4303500A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

AU43035/00A 1999-04-29 2000-04-25 Use of (2s)-1- ((2r,3s)-5-chloro-3- (2-chlorophenyl)- 1-(3,4-dimethoxybenzenesulfonyl)- 3-hydroxy-2,3- dihydro-1(h)- indole-2-carbonyl) pyrrolidine- 2-carboxamide in the production of medicaments used to treat raynaud's phenomenon Abandoned AU4303500A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9905434A FR2792834A1 (en)	1999-04-29	1999-04-29	USE OF SR 49059, ITS PHARMACEUTICALLY ACCEPTABLE SOLVATES AND / OR HYDATES FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OR PREVENTION OF RAYNAUD PHENOMENON
FR9905434		1999-04-29
PCT/FR2000/001085 WO2000066117A1 (en)	1999-04-29	2000-04-25	Use of (2s)-1- [(2r,3s)-5-chloro-3- (2-chlorophenyl)- 1-(3,4-dimethoxybenzenesulfonyl)- 3-hydroxy-2,3- dihydro-1h- indole-2-carbonyl] pyrrolidine- 2-carboxamide in the production of medicaments used to treat raynaud's phenomenon

Publications (1)

Publication Number	Publication Date
AU4303500A true AU4303500A (en)	2000-11-17

Family

ID=9545016

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU43035/00A Abandoned AU4303500A (en)	1999-04-29	2000-04-25	Use of (2s)-1- ((2r,3s)-5-chloro-3- (2-chlorophenyl)- 1-(3,4-dimethoxybenzenesulfonyl)- 3-hydroxy-2,3- dihydro-1(h)- indole-2-carbonyl) pyrrolidine- 2-carboxamide in the production of medicaments used to treat raynaud's phenomenon

Country Status (4)

Country	Link
AR (1)	AR023617A1 (en)
AU (1)	AU4303500A (en)
FR (1)	FR2792834A1 (en)
WO (1)	WO2000066117A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5338755A (en) *	1990-07-31	1994-08-16	Elf Sanofi	N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
FR2679903B1 (en) *	1991-08-02	1993-12-03	Elf Sanofi	DERIVATIVES OF N-SULFONYL INDOLINE CARRYING AN AMIDIC FUNCTION, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.
FR2714378B1 (en) *	1993-12-24	1996-03-15	Sanofi Sa	Indol-2-one derivatives substituted in 3 with a nitrogen group, their preparation, pharmaceutical compositions containing them.
FR2775598A1 (en) *	1998-03-06	1999-09-10	Sanofi Sa	PHARMACEUTICAL COMPOSITIONS COMPRISING A SELECTIVE ANTAGONIST OF ARGININE-VASOPRESSIN V1A RECEPTORS AND A SELECTIVE ANTAGONIST OF ARGININE-VASOPRESSIN V2 RECEPTORS

1999
- 1999-04-29 FR FR9905434A patent/FR2792834A1/en not_active Withdrawn
2000
- 2000-04-25 WO PCT/FR2000/001085 patent/WO2000066117A1/en not_active Ceased
- 2000-04-25 AU AU43035/00A patent/AU4303500A/en not_active Abandoned
- 2000-04-27 AR ARP000101990A patent/AR023617A1/en unknown

Also Published As

Publication number	Publication date
FR2792834A1 (en)	2000-11-03
WO2000066117A1 (en)	2000-11-09
AR023617A1 (en)	2002-09-04

Similar Documents

Publication	Publication Date	Title
AU4067800A (en)	2000-10-23	Surgical bone screw
IL148470A0 (en)	2002-09-12	Electrosurgical coagulating and cutting instrument
AU6779900A (en)	2001-03-13	Discontinuous films from skin care compositions
HUP0101434A3 (en)	2001-10-29	Sulfonamide-containing indole compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same
TWI315989B (en)	2009-10-21	Soy depigmenting and skin care compositions
FR2791684B1 (en)	2001-05-11	COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION CONTAINING THE TRIPEPTIDE N-N-BIOTINYL-GLY-HIS-LYS FOR PREVENTING, REDUCING OR SUPPRESSING HAIR LOSS AS WELL AS TO PROMOTE THEIR GROWTH
AU2003299848A1 (en)	2004-07-22	Intraoral calculus dissolving gel composition
AU6372900A (en)	2001-02-13	Linkage of agents to tissue
AU3573399A (en)	1999-11-16	Skin whitening composition
AU2002258559A1 (en)	2002-10-08	Skin care compositions
AU5186799A (en)	2000-02-07	Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AU2003284225A1 (en)	2004-07-29	Skin care composition containing an anionic polymer
AU2001265253A1 (en)	2002-01-21	Treatment of hiv using hyperthermia
IT1302264B1 (en)	2000-09-05	DERIVATIVES WITH N-ACYL VANILLYAMIDE STRUCTURE ABLE TO ACTIVATE PERIPHERAL IRECEPTORS OF CANNABINOIDS
AU4647200A (en)	2000-11-02	Skin care compositions containing combination of skin care actives
AU2495100A (en)	2000-09-28	Surgical handpiece
AU2001286625A1 (en)	2002-03-04	Personal care compositions containing polymers
AU3338700A (en)	2001-06-18	Zirconium dioxide based material, surgical cutting tools made of zirconium dioxide based material, tools made of zirconium dioxide based material
WO2001012661A3 (en)	2001-09-20	RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-xL FUSION PROTEIN INHIBITS APOPTOSIS
AU2000236008A1 (en)	2001-08-07	Treatment for dry mouth employing carbamide peroxide
AU4361600A (en)	2000-11-02	Skin care compositions containing combination of skin care actives
AU4647300A (en)	2000-11-02	Skin care compositions containing combination of skin care actives
AU4303500A (en)	2000-11-17	Use of (2s)-1- ((2r,3s)-5-chloro-3- (2-chlorophenyl)- 1-(3,4-dimethoxybenzenesulfonyl)- 3-hydroxy-2,3- dihydro-1(h)- indole-2-carbonyl) pyrrolidine- 2-carboxamide in the production of medicaments used to treat raynaud's phenomenon
WO2001043705A3 (en)	2001-12-13	Compositions containing a retinoid and a stilbene for skin care
AU2001271088A1 (en)	2002-01-14	Polyolefin resin composition containing natural antioxidant and thermostabilizerwithout harmful effect to the human body

Legal Events

Date	Code	Title	Description
2002-03-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase